| Veramyst (fluticasone furoate nasal spray) / GSK |
| Not yet recruiting | 4 | 135 | | | Dr John D Brannan, GlaxoSmithKline | Asthma | | | | |
ACTRN12622000232730: Monitoring Intermittent vs Regular inhaled corticoSteroids in asthma: MIRSA study |
|
|
| Not yet recruiting | 4 | 135 | | | Dr John D Brannan, GlaxoSmithKline | Asthma | | | | |
| Ongoing | 4 | 900 | Europe | Fluticasone Furoate, Inhalation powder | GlaxoSmithKline Research & Development Limited, GlaxoSmithKline Research & Development Limited | Paediatric Subjects with Asthma, Paediatric Subjects with Asthma, Diseases [C] - Respiratory Tract Diseases [C08] | | | | |
NCT03315000: Effect of Vilanterol on Methacholine Challenge Results |
|
|
| Completed | 4 | 17 | Canada | Vilanterol and Fluticasone Furoate, Breo, Fluticasone Furoate, Arnuity, Placebos, lactose powder | University of Saskatchewan | Asthma | 05/18 | 05/18 | | |
NCT03898466: Effect of Fluticasone Furoate on Methacholine Challenge |
|
|
| Completed | 4 | 14 | Canada | Fluticasone furoate, Arnuity, Matching placebo | University of Saskatchewan | Asthma | 04/19 | 04/19 | | |
NCT02889809: Effects of a Orally Inhaled Fluticasone Furoate on Growth Velocity in Prepubertal, Paediatric Subjects With Asthma Over a Year |
|
|
| Completed | 4 | 477 | Europe, US, RoW | Fluticasone furoate, Placebo, Montelukast, Short Acting Beta 2 Agonist | GlaxoSmithKline | Asthma | 04/21 | 06/21 | | |
